Safety in moderate‐to‐severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti‐tuberculosis treatments concomitantly: Results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trials
Journal of the European Academy of Dermatology and Venereology | Apr 19, 2020
Most read this week